Live Dana-Farber Cancer Institute News with Latest Updates

Live Dana-Farber Cancer Institute news and developments with the latest updates. Check out current Dana-Farber Cancer Institute news stories and find out what happened, what is going on with Dana-Farber Cancer Institute. Recent news updates about Dana-Farber Cancer Institute
Hale Family to Accelerate Pancreatic Cancer Research and Care with One of Largest Single Gifts Ever to Dana-Farber Cancer Institute
Dana-Farber announces $4 million funding opportunity to improve community health by increasing access to services
Esophageal Cancers Resurrect Ancient Retroviruses Hidden in Our Genome
Christopher Lathan appointed Chief Clinical Access and Equity Officer at Dana-Farber
Christopher Lathan appointed Chief Clinical Access and Equity Officer at Dana- Farber
Heidi E. Conway joins Dana-Farber to lead Human Resources Department
Dana-Farber and Harvard Street Neighborhood Health Center to connect patients to cancer services
For young patients with breast cancer, fertility concerns influence endocrine therapy decisions, study finds
Ludwig Princeton’s Eileen White and Ludwig Harvard’s Alan D’Andrea elected to National Academy of Sciences
Using CRISPR as a research tool to develop cancer treatments
Dana-Farber Cancer Institute faculty recognized as 2021 ASCO leaders in cancer care
Dana-Farber joins Multi-Cancer Early Detection Consortium to chart path forward for use of new technologies to improve early cancer
Dana-Farber nurses present research at 2021 Oncology Nursing Society Congress
Dana-Farber Cancer Institute receives 2021 Community Hero Award presented by Make-A-Wish Massachusetts and Rhode Island
Level of chromosomal abnormality in non-small cell lung cancer may predict response to immunotherapy
Dana-Farber to present more than 30 research studies at American Association for Cancer Research Annual Meeting 2021
Excellent outcomes reported for first targeted frontline therapy for high-risk pediatric Hodgkin lymphoma
Gift supports research into rare cancers, community-building
Breast Cancer Survivors’ Fear of Cancer Returning Linked to Genomic Test Results, Psychological Factors
Low-calorie diet and mild exercise improve survival for young people with leukemia
George Demetri, MD elected as a Fellow of American Association for Cancer Research Academy
Expert panel issues recommendations for addressing cancer inequities
First FDA approval of CAR T-cell therapy for multiple myeloma marks milestone for patients
New sequencing approach finds triple-negative breast cancers continue accumulating genetic changes during tumor growth
Study underscores need for multidisciplinary care for COVID-19 long-haulers
Lynch Syndrome: Know your risk for susceptibility to cancer
New targeted agent achieves impressive response rate in trial with patients with uterine serous carcinoma
Dana-Farber research leads to better understanding of immune system in kidney cancer
Bruce Spiegelman receives high honor from American Diabetes Association
Dana-Farber to offer first CAR T-cell therapy for indolent follicular lymphoma following FDA approval
Childhood Cancer Survivors, Providers Satisfied with Video Visits for Long-term Follow-up
Stuart Orkin receives $500,000 Gruber Genetics Prize for his groundbreaking research on genetics of inherited blood disorders
Immunotherapy combination improves outcomes in advanced kidney cancer 4 March
Dana-Farber announces initiatives for Colorectal Cancer Awareness month in March
Break Through Cancer launches collaborative model across top U.S. research institutions in pursuit of cancer cures
Break Through Cancer launches collaborative model with MD Anderson, top U.S. research institutions
CAR T-cell therapy generates lasting remissions in patients with multiple myeloma
New recommendations aim to eliminate racial bias in myeloma trials
Dana-Farber, Broad Institute and Count Me In receive $16 million grant to launch patient-partnered research initiatives
Dana-Farber Cancer Institute Joins Caris’ Precision Oncology Alliance
Laurie H. Glimcher, MD, named to Modern Healthcare’s Women Leaders Luminaries list
Dana-Farber Medical Oncology Chair receives Sjöberg Prize for cancer research
Immunotherapy – targeted drug combination improves survival in advanced kidney cancer
Dana-Farber Cancer Institute and Deerfield Management Launch Riverway Discoveries
First mammography screening guidelines issued for older survivors of breast cancer
“Nuclear Physics”: Imaging into Heart of a Cell
Noninvasive blood test tracks organ injury from COVID-19
Dana-Farber to hold a discussion for cancer patients and survivors about Covid-19 vaccine